Previous symbols: LQT, KCNA9. Aliases: Kv7.1, KCNA8, KVLQT1, JLNS1, LQT1.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Familial Atrial Fibrillation | causative germline |
mechanism: Atrial Ion-Channel or Coupling Variant; Shortened Atrial Action Potential and Refractoriness
subtype: KCNQ1-related
scoped to subtype: KCNQ1-related
|
| Familial Long QT Syndrome | causative |
mechanism: Reduced Repolarizing Potassium Current
subtype: Type 1
computational model: O'Hara-Rudy (ORd) Human Ventricular Action Potential Model
scoped to subtype: Type 1
|
| Jervell and Lange-Nielsen Syndrome 1 | causative germline loss of function |
mechanism: Biallelic KCNQ1 Loss-of-Function Variants
|
| Hereditary Gingival Fibromatosis |
untyped
Modifier/Mechanistic
|
mechanism: Constitutive RAS-MAPK Signaling in Gingival Fibroblasts
|
| Short QT Syndrome |
untyped
Causative
|
mechanism: Ion-channel gain- and loss-of-function variants
subtype: SQTS2
scoped to subtype: SQTS2
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| short QT syndrome MONDO:0000453 | AD | Strong 2020-10-27 |
Short QT Syndrome
untyped
|
| Jervell and Lange-Nielsen syndrome MONDO:0002441 | AR | Definitive 2017-12-19 |
no dismech entry |
| long QT syndrome MONDO:0002442 | AD | Definitive 2018-09-25 |
no dismech entry |
| hypertrophic cardiomyopathy MONDO:0005045 | AD | Disputed 2022-05-09 |
Hypertrophic Cardiomyopathy
not named
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.